Kathryn DiMarco - Feb 9, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Corporate Controller
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kathryn DiMarco
Stock symbol
OGN
Transactions as of
Feb 9, 2023
Transactions value $
-$21,963
Form type
4
Date filed
2/10/2023, 05:04 PM
Previous filing
May 11, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +1.87K +68.06% $0.00 4.62K Feb 9, 2023 Direct F1
transaction OGN Common Stock Tax liability -$22K -740 -16.03% $29.68 3.88K Feb 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -1.87K -50% $0.00 1.87K Feb 9, 2023 Common Stock 1.87K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.
F3 On each of February 9, 2022 and February 9, 2023, one-third of the RSUs vested with the remaining RSUs to vest on February 9, 2024.